Strive prices upsized IPO of preferred stock at $90 per share

City Therapeutics has priced its IPO at $18 per share, successfully raising $200M in capital. Simultaneously, Strive has priced an upsized IPO of preferred stock, setting the price at $90 per share. Both companies have completed these specific pricing actions for their respective public offerings to secure investment. These financial developments mark significant milestones for City Therapeutics and Strive as they navigate their initial public offerings within their respective market sectors to raise necessary funds.